Virtu Financial LLC Shattuck Labs, Inc. Transaction History

Virtu Financial LLC

$1.89 Billion
Q4 2024

A detailed history of Virtu Financial LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 24,446 shares of STTK stock, worth $30,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,446

Holding current value

$30,068

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 11, 2025	BUY	$1.0 - $1.92 $24,446 - $46,936	24,446 New	24,446 $30,000
Q1 2024 May 20, 2024	BUY	$7.37 - $10.09 $92,810 - $127,063	12,593 New	12,593 $113,000

Others Institutions Holding STTK

# of Institutions

Shares Held

31.3M

Call Options Held

Put Options Held

Prosight Management, LP Dallas, TX

6.64M
Shares

$8.17 Million
2.39% of portfolio
Redmile Group, LLC San Francisco, CA

5.54M
Shares

$6.81 Million
0.52% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.68M
Shares

$5.75 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.47M
Shares

$3.04 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.41M
Shares

$2.96 Million
0.0% of portfolio

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $52.1M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account